Abstract
Over the last decade, the basement membrane or basal lamina of the adult skeletal muscle fiber has been emphasized as playing an important, if not critical, role in muscle regeneration after injury[1-9]. A concept of considerable stability and persistence of this structure or several components of it, has developed from studies principally in the frog that suggest it has major roles in the reinnervation of denervated adult muscle over and above any potential contributions by the principal cellular elements: nerve axon, Schwann cell or muscle fiber itself, in this process[10, 11]. In the last few years other studies suggest that one or more macro- molecules within the synaptic region of the basement membrane influence or cause the accumulation of acetylcholine receptors (AChRs) in the absence of the nerve[12,13]. Using much the same experimental paradigm, these same authors conclude that the same or different molecules, ‘stably’ attached to the synaptic basal lamina, regulate or ‘direct’ the accumulation of acetylcholinesterase (AChE), again at original synaptic sites[14].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. Allbrook, Skeletal muscle regeneration, Muscle & Nerve, 4: 234–245 (1981).
R. Vracko and E. P. Benditt, Basal lamina: the scaffold for orderly cell replacement, observations on regeneration of injured skeletal muscle fiber and capillaries, J. Cell Biol., 55: 406–419 (1972).
A. K. Gulati, A. H. Reddi, and A. A. Zalewski, Changes in the extra cellular matrix components laminin and fibronectin during immune rejection of skeletal muscle, Anatomical Record, 204: 175–183 (1982).
A. K. Gulati, A. H. Reddi, and A. A. Zalewski, Changes in the basement components during skeletal muscle fiber degeneration and regeneration, J. Cell Biol., 97: 957–962 (1983).
A. K. Gulati, A. A. Zalewski, and A. H. Reddi, An immunofluorescent study of the distribution of fibronectin and laminin during limb regeneration, Dev.Biol., 96: 355–365 (1983).
A. K. Gulati, Basement membranes component changes in skeletal, muscle transplants undergoing regeneration or rejection, J. Cell. Biochem., 27: 337–346 (1985).
J. R. Sanes and J. C. Lawrence, Jr., Activity dependent accumulation of basal lamina by cultured rat myotubes, Dev. Biol., 97: 123–136 (1983).
J. R. Sanes, Roles of extracellular matrix in neuronal development, Ann. Rev. Physiol., 45: 581–600 (1983).
L. Anglister and U. J. McMahan, Extracellular matrix components involved in neuromuscular transmission and regeneration, Ciba Foundation Symposium, 108: 163–178 (1984).
M. S. Letinsky, K. H. Fischbeck, and U. J. McMahan, Precision of reinnervation of original postsynaptic sites in frog muscle after a nerve crush, J. Neurocytol., 5: 691–718 (1976).
J. R. Sanes, L. M. Marshall, and U. J. McMahan, Reinnervation of muscle fiber basal lamina after removal of myofibers. Differentiation of regenerating axons of original synaptic sites, J. Cell Biol., 78: 176–198 (1978).
S. Burden, P. Sargent, and U. J. McMahan, Acetylcholine receptors in regenerating muscle accumulate at original synaptic sites in the absence of the nerve, J.Cell Biol., 82: 412–425 (1979).
R. M. Nitkin, B. G. Wallace, M. E. Spira, et al., Molecular components of the synaptic basal lamina that direct differentiation of regenerating neuromuscular junctions, Cold Spring Harbor Symp., 48: 653–665 (1983).
L. Anglister and U. J. McMahan, Basal lamina directs acetylcholine esterase accumulation at synaptic sites in regenerating muscle, J. Cell Biol., 101: 735–743 (1985).
D. C. Van Essen, Neuromuscular synapse elimination, in: “Neuronal Development”, N. C. Spitzer, ed., pp. 333–376, Plenum Press, New York (1982).
D. Purves and J. W. Lichtman, Elimination of synapses in the developing nervous system, Science, 210: 153–157 (1980).
D. Purves and J. W. Lichtman, “Principles of Neural Development”, Sinauer, Sunderland, Massachusetts (1984).
D. Wigston and J. Sanes, Selective reinnervation of adult mammalian muscle by axons from different segmental levels, Nature, 299: 464–467 (1982).
J. L. Bixby and D. C. Van Essen, Competition between foreign and original nerves in adult mammalian skeletal muscle, Nature (London), 282: 276–278 (1979).
B. W. Festoff, Role of neuromuscular junction macromolecules in the pathogenesis of amyotrophic lateral sclerosis, Med. Hypotheses, 6: 121–131 (1980).
E. D. Hay, ed., “Cell Biology of the Extracellular Matrix”, Plenum Press, New York (1982).
R. Timpl, Molecular aspects of basement membrane structure, Prog. Clin.Biol.Res., 171: 63–74 (1985).
N. A. Kefalides, R. Alper, and C. C. Clark, Biochemistry and metabolism of basement membranes, Int.Rev.Cytol., 61: 167–228 (1979).
R. Timpl and G. R. Martin, in: “Immunochemistry of the Extracellular Matrix”, Vol.2, H. Furthmayer, ed., CRC Press, Boca Raton (1982).
H. L. Fernandez, M. J. Duell, and B. W. Festoff, Cellular distribution of 16S acetylcholinesterase, J.Neurochem., 32: 581–585 (1979).
H. L. Fernandez, M. J. Duell, and B. W. Festoff, Neurotrophic regulation of 16S acetylcholinesterase at the vertebrate neuromuscular junction, J.Neurobiol., 10: 442–454 (1979).
H. L. Fernandez, M. J. Duell, and B. W. Festoff, Bi-directional axonal transport of 16S acetylcholinesterase in rat sciatic nerve, J.Neurobiol., 10: 31–39 (1980).
B. W. Festoff, Release of acetylcholinesterase in amyotrophic lateral sclerosis, in: “Pathogenesis of Human Motor Neuron Diseases”, L. P. Rowland, ed., pp. 503 - 516, Raven Press, New York (1982).
J. Massouli£, The polymorphism of cholinesterase and its physiological significance, Trends Biochem.Sci., 5: 160–164 (1980).
S. Bon, J. Cartaud, and J. Massouli£, The dependence of acetylcholine esterase aggregation at low ionic strength upon a polyanionic component, Eur.J.Biochem., 85: 1–14 (1978).
J. Sketelj, and M. Brzin, Attachment of acetylcholinesterase to structures of the motor endplate, Histochem., 61: 239–248 (1979).
J. Grassi, J. Massouli£, and R. Timpl, Relationship of collagen-tailed acetylcholinesterase with basal lamina components absence of binding with laminin, fibronectin and collagen types IV and V and lack of reactivity with different anti-collagen sear, Eur.J. Biochem., 133: 31–38 (1983).
M. Vigny, G. R. Martin, and G. R. Grotendorst, Interactions of asymmetric forms of acetylcholinesterase with basement membrane components, J.Biol.Chem., 258: 8794–8798 (1983).
E. Brandan and N. C. Inestrosa, Binding of the asymmetric forms of acetylcholinesterase to heparin, Biochem.J., 221: 415–422 (1984).
E. Brandan, M. Moldonado, J. Garrido, and N. C. Inestrosa, Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparin sulfate proteoglycan, J.Cell Biol., 101: 985–992 (1985).
H. L. Fernandez and M. J. Duell, Protease inhibitors reduce effects of denervation on muscle endplate acetylcholinesterase, J. Neurochem. (1980).
H. L. Fernandez, M. R. Patterson, and M. J. Duell, Neurotrophic control of 16S acetylcholinesterase from mammalian skeletal muscle in organ culture, J.Neurobiol., 11: 557–570 (1980).
B. W. Festoff, Protocol for a model therapeutic trial in amyotrophic lateral sclerosis, in: “Research Progress in Motor Neurone Disease”, F. C. Rose, ed., pp. 432–442, Pitman, London (1984).
B. W. Festoff, K. L. Oliver, and N. B. Reddy, In vitro studies of muscle membranes. Effects of denervation on the macromolecular components of cation transport in red and white skeletal muscle, J.Membr.Biol., 32:345–360 (1977).
D. Hantai and B. W. Festoff, Muscle adhesive basement membrane proteins are degraded by plasminogen activator in the presence of plasminogen, in: “Molecular Neurobiology”, E. Kandel and R. Levi- Montalcini, eds., Springer-Verlag, Berlin (1986) (in press).
B. W. Festoff, M. R. Patterson, and K. Romstedt, Plasminogen activator: the major secreted neutral protease of cultured skeletal muscle cells, J.Cell.Physiol., 110: 190–195 (1982).
B. W. Festoff, M. R. Patterson, D. Eaton, and J. B. Baker, Plasminogen activator and protease nexin in myogenesis, J.Cell.Biol., 91: 43a (1981).
M. Ramby, B. Norman, and P. Wallen, A sensitive assay for tissue plasminogen activator, Thromb.Res., 27: 743–748 (1982).
A. Granelli-Piperno and E. Reich, A study of protease and protease inhibitor complexes in biological fluids, J. Exp. Med., 148: 223–234 (1983).
A. Smokovitis and T. Astrup, Localization of fibrinolytic activity and inhibition of plasmin in the spinal cord of rat, guinea pig and rabbit, J. Neurosurg., 48: 1008–1014 (1978).
K. Danø, P. A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver, Plasminogen activators, tissue degradation and cancer, Adv.Cancer Res., 40: 139–266 (1985).
D. L. Eaton and J. B. Baker, Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor, J.Cell Physiol., 117: 175–182 (1983).
J. B. Baker, D. A. Low, R. L. Simmer, and D. D. Cunningham, Protease nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells, Cell, 21: 37–45 (1980).
J. B. Baker, D. A. Low, D. L. Eaton, and D. D. Cunningham, Thrombin mediated mitogenesis: the role of secreted protease nexin, J.Cell. Physiol., 112: 291–297 (1982).
B. Wiman, G. Mellbring, and M. Ranby, Plasminogen activator release during venous stasis and exercise as determined by a new specific assay, Clin.Chem.Acta, 127: 279–288 (1983).
B. W. Festoff and H. L. Fernandez, Plasma and red cell acetylcholine esterase in amyotrophic lateral sclerosis, Muscle and Nerve, 4: 41–47 (1981).
D. C. Rijken and D. Collen, Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture, J.Biol.Chem., 256: 7035–7041 (1981).
H. M. Fullmer, H. D. Seidler, R. S. Krooth, and L. T. Kurland, A cutaneous disorder of connective tissue in amyotrophic lateral sclerosis, Neurology (Minneap.), 10: 717–721 (1960).
H. M. Fullmer, W. A. Gibson, G. Lazarus, A. C. Stam, Jr., and C. Link, Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis, Lancet, 1: 1007–1009 (1966).
L. Beach, E. T. Reyes, B. W. Festoff, R. Yanagihara, D. C. Gajdusek, and J. S. Rao, Collagenase activity in skin fibroblasts of patients with amyotrophic lateral sclerosis, J.Neurol.Sci. 72: 49–60 (1986).
Z. Werb and J. Aggeler, Proteases induce secretion of collagenase and plasminogen activator by fibroblasts, Proc.Natl.Acad.Sci., USA., 75: 1839–1843 (1978).
M. Senior and E. J. Campbell, Neutral proteinases from human inflammatory cells, Clin.Lab.Med., 3: 645–666 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Festoff, B.W. (1987). Proteases, Their Inhibitors and the Extracellular Matrix: Factors in Nerve-Muscle Development and Maintenance. In: Cosi, V., Kato, A.C., Parlette, W., Pinelli, P., Poloni, M. (eds) Amyotrophic Lateral Sclerosis. Advances in Experimental Medicine and Biology, vol 209. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5302-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5302-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5304-1
Online ISBN: 978-1-4684-5302-7
eBook Packages: Springer Book Archive